NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News → The Military's $700M 'AI Software Bullet' (From Behind the Markets) (Ad) Free LABU Stock Alerts $106.61 -4.29 (-3.87%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$104.85▼$109.9750-Day Range$83.72▼$120.8452-Week Range$48.40▼$176.99Volume1.56 million shsAverage Volume2.63 million shsMarket Capitalization$1.11 billionAssets Under Management$1.01 billionDividend Yield0.59%Net Expense Ratio0.96% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get Direxion Daily S&P Biotech Bull 3x Shares alerts: Email Address About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Read More LABU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABU ETF News HeadlinesJune 9, 2024 | americanbankingnews.comDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Gap Down to $115.82May 17, 2024 | investing.comDirexion Daily FTSE Europe Bull 3X Shares (EURL)April 2, 2024 | investorplace.comThe 3 Best Leveraged ETFs for April 2024March 21, 2024 | msn.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1606March 4, 2024 | seekingalpha.comLABU: A Really Bad DriftJanuary 22, 2024 | finance.yahoo.comDirexion Daily S&P Biotech Bull 3X Shares (LABU)December 16, 2023 | seekingalpha.comLABU: Buy As The Biotech Sector Starts A New Bull Market (Technical Analysis)December 10, 2023 | seekingalpha.comLABU: Tool For Swing TradersSee More Headlines Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings154 Fund Statistics Assets Under Management$1.01 billion Average Daily Volume$1.70 million Discount/Premium0.17% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume8,396 Put Options3,992 Call Options4,404 Short Interest1,370,000 shs Miscellaneous Outstanding Shares10,420,000Beta3.31 Creation Unit50,000 Creation Fee$250.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.54%0.51%0.51%Other Expenses0.21%0.33%0.50%0.59%0.54%Total Expense0.96%0.70%0.70%0.74%0.71%Fee Waiver0.00%-0.45%-0.55%-0.69%-0.60%Net Expense0.96%0.61%0.60%0.58%0.58% Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings & ExposureTop 10 LABU HoldingsS&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 44.87%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 41.47%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 39.55%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 37.22%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 32.83%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 29.15%DREYFUS GOVT CASH MAN INSHolding Weight: 25.93%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 13.63%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 7.30%DREYFUS TRSRY SECURITIES CASH MGMTHolding Weight: 4.49%LABU Sector ExposureLABU Industry ExposureFull Holdings Details Similar ETFsFirst Trust NYSE Arca Biotechnology Index FundNYSEARCA:FBTInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHFirst Trust Health Care AlphaDEX FundNYSEARCA:FXHiShares U.S. Healthcare Providers ETFNYSEARCA:IHFInstitutional OwnershipTidal Investments LLCBought 14,000 shares on 5/17/2024Ownership: 0.134%SG Americas Securities LLCSold 356 shares on 5/7/2024Ownership: 0.011%Quantbot Technologies LPSold 284 shares on 5/6/2024Ownership: 0.023%McGuire Investment Group LLCBought 470 shares on 4/26/2024Ownership: 0.047%Gainplan LLCBought 5,000 shares on 4/25/2024Ownership: 0.051%View All Institutional Transactions LABU ETF - Frequently Asked Questions How have LABU shares performed in 2024? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $121.97 at the beginning of the year. Since then, LABU stock has decreased by 12.6% and is now trading at $106.61. View the best growth stocks for 2024 here. What does LABU invest in? Direxion Daily S&P Biotech Bull 3x Shares is a equity fund issued by Direxion. LABU focuses on health care investments and follows the S&P Biotechnology Select Industry Index. The fund's investments total to approximately $1.01 billion assets under management. What stocks does Direxion Daily S&P Biotech Bull 3x Shares hold? LABU invests in 154 holdings. Some of the stocks in their portfolio include Novavax (NVAX), Insmed (INSM), Moderna (MRNA), Twist Bioscience (TWST), Revolution Medicines (RVMD), PTC Therapeutics (PTCT), Natera (NTRA), Dyne Therapeutics (DYN), BioCryst Pharmaceuticals (BCRX) and Agios Pharmaceuticals (AGIO). What is the management fee for Direxion Daily S&P Biotech Bull 3x Shares? Direxion Daily S&P Biotech Bull 3x Shares' management fee is 0.75% and has other expenses of 0.21%. The net expense ratio for LABU is 0.96%. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Direxion Daily S&P Biotech Bull 3x Shares's stock reverse split on Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), NVIDIA (NVDA), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Alibaba Group (BABA), ProShares UltraPro QQQ (TQQQ), Advanced Micro Devices (AMD), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Boeing (BA), Gilead Sciences (GILD). Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Direxion Daily S&P Biotech Bull 3x Shares' stock is owned by a number of retail and institutional investors. Top institutional investors include TB Alternative Assets Ltd. (0.04%), Tidal Investments LLC (0.13%), Traynor Capital Management Inc. (0.00%), Gainplan LLC (0.05%), McGuire Investment Group LLC (0.05%) and Quantbot Technologies LP (0.02%). How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:LABU) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.